Cureus · 2020 · 12 citations · 11 references
MedicineHematologyPharmacologyAntimicrobial PharmacotherapyClinical PharmacologySepsisAntibiotic ResistanceHealthcare-associated InfectionsHematologic ToxicityJoint InfectionsMyelosuppression ManagementSeptic ArthritisLinezolid TherapyMethicillin-resistant Staphylococcus Aureus Infection TreatmentMethicillin-resistant Staphylococcus Aureus TreatmentSeptic Arthritis Antibiotic ManagementSeptic Arthritis Complications
Bone marrow suppression has a wide variety of causes. One of the overlooked causes is linezolid, a drug that is now being extensively used in the management of not only soft tissue infections but also hospital-acquired infections. Methicillin-resistant Staphylococcus aureus (MRSA) is widely being treated with linezolid. It becomes imperative that we comprehensively understand the hematological adverse effect profile of this drug. A reversible myelosuppression is seen with its extended use, though a number of risk factors like renal impairment are usually present. A prompt diagnosis can help us to timely discontinue the drug. We report one such case of an elderly patient with septic arthritis of the knee who developed pancytopenia after 32 days of linezolid therapy. Withdrawal of the drug led to a complete recovery of the blood counts in 21 days.
11
A method for estimating the probability of adverse drug reactions
C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations
Hematologic Effects of Linezolid: Summary of Clinical Experience
Stanton L. Gerson, Sheldon L. Kaplan, Jon Bruss et al. · Antimicrobial Agents and Chemotherapy · 2002 · 443 citations · Full text
Medicine, Hematology, Pharmacology +14
Mechanisms for Linezolid-Induced Anemia and Thrombocytopenia
Wendy B. Bernstein, Richard F. Trotta, James T. Rector et al. · Annals of Pharmacotherapy · 2003 · 183 citations